Expert Links Actos To Bladder Cancer In Philly Trial
A Columbia University cancer researcher told a Philadelphia jury on Thursday that scientific studies supported a conclusion that the Takeda Pharmaceutical Co. diabetes drug Actos contributed to the development of malignant...To view the full article, register now.
Already a subscriber? Click here to view full article